Meridian Bioscience, Inc. (VIVO)
Loading...
Symbols:
VIVO Forum Topics
loading ...Recent VIVO Articles
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Freedland
Why I'm Taking a Chance on Meridian [view article]
Jake,No I am not a masochist. I now have unloaded 1500 of those 2000 shares at about an average gain of 1.5 points.
Trying to keep my hands off the last 500 for awhile.
Just lucky I guess. Sometimes it pays to swim against the tide. Usually I have to call a lifeguard to pull me out :). Reply
Why I'm Taking a Chance on Meridian [view article]
Well, even an upgrade is sufficient for a 10% move...as happening today! This is an excellent company and stock (has been outperforming SP500 by 39.2 37.0 20.0 points for 3, 5 and 10 year periods...(morningstar... 20+ ROA and ROE. Add on dips (selling short term calls during earnings has been "good" for the past 2 announcements)..... Disclosure: Long VIVO ReplyWhy I'm Taking a Chance on Meridian [view article]
I agree with you Robert. Way oversold . I own some Oct 25 calls @ around $4 and got clobbered. Down about 50% but I wouldn't need much of a bounce to even again.Any drift down to $22.50 and I will be buying those ITM Jan-09. Last earnings it took a serious implosion only to consolidate and recover $3+. I give it about a month and we should be up %10. With ITM options a 10 % would = equal about an 80-100% move then you sell short calls against it. Great strategy if you call the direction right.
Reply
Why I'm Taking a Chance on Meridian [view article]
Are you a masochist? ReplyThe Long Case on Meridian Bioscience [view article]
I bought this stock back at around $11-12/share, and then revelled in the 3:2 split, and have been doing the "Snoopy" dance since researching how deep they are making their own pipeline. Management is sticking to what they know and do best, and are obviously quite adept at doing just that showing a true Midas touch. I also almost pulled the trigger to sell when the price reached $36.25 just 3/4 below their 52wk high. But after watching the stock's strength in the face of these market conditions, as well as knowing how they are not resting their R & D department, I just couldn't pull the trigger. Instead, I opted for a stop loss at $29. Why? If you look at a 6-month chart going back to the middle of November 2007, you will see that 5x this stock bounced sharply off the $29 mark. Specifically, it shot to around $33, $36, $33, $36, and $37 respectively each time it bounced off $29. Those, in and of themselves are not peanut trades. That's $30 worth of pickups in just 5 months time!Anyway, as with Bob this is definitely my most successful and largest holding of the last 18 months thanks to great management, and great products and pipeline. The dividend is just icing on the cake as it provides both growth and income (dividends are reinvested). I, too, am cautious and well aware about growth issues with regards to the stock price, but I'm not down at all on the company. I just feel that I've covered myself in that regard by setting that stop loss at a point I'm comfortable with - and believe me, should I get stopped out, I will have my eyes open for signs of stabilization in price and trading to look for a new entry point!
Art Reply
Freedland
The Long Case on Meridian Bioscience [view article]
Thank you for pointing that out! I tend to concentrate on the proven performance of stocks and haven't been trying to calculate the impact of future developments as you suggest. But this is certainly an important point to consider.Bob Reply
The Long Case on Meridian Bioscience [view article]
Nice article, but failure to mention the current vaccine trial or the other nine that Meridian has an authorization from the National Institute of Health to bring to FDA trial and commercialize, leave out a possible huge future increase in growth. Their in house research produces enough new tests yearly to maintain the current growth rate. ReplyEditors
General Discussion on VIVO
Is this a buy or a sell? ReplyBrochstein
Small-Cap Growth: Analyst Coverage Discount? [view article]
That's a good point. I do tend to use high analyst ratings as a negative input, though WHQ didn't really have such strong opinion behind it. I think that there is a persistent investment arbitrage potential in buying the names that aren't so recognized and trading them out potentially when they become recognized. Replyinvestor
Small-Cap Growth: Analyst Coverage Discount? [view article]
Alan, the analyst optimism in WHQ would appear to be misplaced, at least in the short term, after the pre-announcement and lower guidance for the company. Your screen might be improved if a sell discipline was built. Maybe there's a "critical mass" of analysts at which excessive optimism is sure to result in underperformance. Given there's a finite number of sell-side firms with any real power over sentiment, there might be a trigger to sell when all the bulge-bracket firms cover a stock. (Note that I'm *not* suggesting that smaller-firm sell-side or independent analysts can't be more "right" than the big boys, just that they by definition they reach fewer people who actually follow their advice (blindly or not). ReplySmall-Cap Growth: Analyst Coverage Discount? [view article]
Well writen with brevity. Two thumbs up! ReplySmall-Cap Growth: Analyst Coverage Discount? [view article]
Well writen with brevity. Two thumbs up! Reply